Astrana Health Overview
Latest P/E ratio for Astrana Health: 45.89 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow45.89
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, ASTH shows a P/E ratio of 45.89. That is above the Healthcare sector average of 24.78. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 24.78. Astrana Health is at 45.89, which is higher that average. That is roughly 85.2% above the sector mean. Use the comparison chart on this page to see how ASTH stacks up against individual peers as well.
Investors watch ASTH's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Astrana Health's latest reading is 45.89. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Astrana Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 45.89) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 24.78, while ASTH is at 45.89. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
